STAT June 13, 2024
Elizabeth Schmidt

The Supreme Court unanimously shut down one of many troubling tugs of war over access to abortion. By tossing out FDA v. Alliance for Hippocratic Medicine, it quashed the utterly mistaken notion that the Food and Drug Administration improperly approved mifepristone, a drug used for medical abortion, nearly a quarter century ago.

This Texas-based case, which sought to roll back access to one of two abortion medications, was not really about anti-abortion doctors supposedly being harmed by the government’s actions. It was about a political drive to unfairly question and restrict a longstanding, safe, and sometimes necessary medical treatment to end pregnancies.

Mifepristone’s safety record is firm: it has been used in more than 630 clinical trials, 420 of which...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Congress / White House, Govt Agencies, Patient / Consumer, Provider, States
What is a Consumer Health Company? Riffing Off of Deloitte’s Report on CHCs/A 2Q2025 Look at Self-Care Futures
The Key to Solving Medication Errors is At The Intersection of Technology and Standards
Medicaid cuts could hurt older adults who rely on home care, nursing homes
Avoidable deaths dropped worldwide – but not in the US
Eli Lilly Adds Alzheimer’s Care to Digital Health Platform Services

Share This Article